Free tool
Stocks near their 52-week high
We cover 87 companies trading within 5% of their own 52-week high. The median market value in the group is $4.26B. Across the group, the median move over the past trading day is 0.00%. 99% of the 86 with a 200-day average trade above it. Price change over the past year runs from +7.7% to +195.1% across the middle 80 percent of the group, with a median of +55.6%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
87 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% |
| JNJB34.SA | Johnson & Johnson | 92.80 BRL | +2.16% | +24.99% | +47.82% |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% |
| ABBV34.SA | AbbVie Inc. | 84.88 BRL | −0.29% | +9.50% | +21.88% |
| MRCK34.SA | Merck & Co., Inc. | 101.37 BRL | +20.05% | +39.73% | +81.07% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| RHO.DE | Roche Holding AG | 405.40 EUR | +2.01% | +14.00% | +41.42% |
| AMGN34.SA | Amgen Inc. | 81.32 BRL | +13.94% | +69.69% | +47.79% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $365.08 | +18.01% | +17.50% | +47.78% |
| TWST | Twist Bioscience Corporation | $150.06 | +69.46% | +363.29% | +451.89% |
| DEMANT.CO | Demant A/S | 284.60 DKK | +0.21% | +33.36% | +17.12% |
| IMVT | Immunovant, Inc. | $43.89 | +12.83% | +69.39% | +189.13% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% |
| SRRK | Scholar Rock Holding Corporation | $60.04 | +21.61% | +40.28% | +74.18% |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% |
| HNGE | Hinge Health, Inc. | $90.50 | +20.27% | +98.64% | +56.66% |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% |
| E2XE34.SA | Exelixis, Inc. | 137.40 BRL | −2.25% | +23.92% | +23.92% |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% |
| TFX | Teleflex Incorporated | $138.74 | +3.38% | +13.97% | +8.06% |
| SHC | Sotera Health Company | $19.54 | +10.02% | +10.46% | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $90.54 | +15.65% | +4.73% | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $29.58 | +13.73% | +12.51% | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $26.36 | +1.78% | +42.49% | +93.26% |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $34.95 | +6.91% | +81.01% | +50.93% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 23.00 EUR | +3.84% | +58.22% | +1.26% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% |
| PGEN | Precigen, Inc. | $7.42 | +34.18% | +73.36% | +61.66% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| PHVS | Pharvaris N.V. | $37.00 | +9.97% | +39.73% | +55.59% |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| ADUS | Addus HomeCare Corporation | $120.71 | +1.25% | +13.26% | +4.50% |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% |
| MD | Pediatrix Medical Group, Inc. | $26.95 | +0.34% | +26.59% | +56.87% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| SEM | Select Medical Holdings Corp | $16.51 | −0.12% | +12.30% | +28.14% |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,970.00 JPY | +5.37% | +57.28% | +79.12% |
| 004080.KS | Shinhung Co., Ltd | 14,080.00 KRW | +0.28% | +0.57% | +2.54% |
| RLYB | Rallybio Corporation | $16.88 | +4.49% | +198.44% | +257.63% |
| INIFY.OL | INIFY Laboratories AB | 7.95 NOK | −3.05% | +65.63% | +44.55% |
| 7702.T | JMS Co.,Ltd. | 459.00 JPY | +1.32% | +5.64% | +6.20% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| INCR | InterCure Ltd. | $5.95 | +546.74% | +477.67% | +265.03% |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% |
| RNXT | RenovoRx, Inc. | $1.49 | +64.28% | +78.44% | +61.08% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| ENP.AX | Entropy Neurodynamics Limited | 0.04 AUD | +17.14% | +28.12% | +10.81% |
| 7091.T | Living Platform,Ltd. | 1,285.00 JPY | +7.98% | +22.20% | +34.42% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| 7129.T | Miahelsa Holdings Corporation | 1,155.00 JPY | +0.09% | +2.17% | +4.87% |
| 9220.T | FB Care Service Co.,Ltd. | 1,287.00 JPY | +3.96% | +12.06% | +11.55% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +50.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.